Correlation Between Enliven Therapeutics and Ikena Oncology
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and Ikena Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and Ikena Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and Ikena Oncology, you can compare the effects of market volatilities on Enliven Therapeutics and Ikena Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of Ikena Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and Ikena Oncology.
Diversification Opportunities for Enliven Therapeutics and Ikena Oncology
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Enliven and Ikena is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and Ikena Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ikena Oncology and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with Ikena Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ikena Oncology has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and Ikena Oncology go up and down completely randomly.
Pair Corralation between Enliven Therapeutics and Ikena Oncology
Given the investment horizon of 90 days Enliven Therapeutics is expected to generate 2.27 times more return on investment than Ikena Oncology. However, Enliven Therapeutics is 2.27 times more volatile than Ikena Oncology. It trades about -0.09 of its potential returns per unit of risk. Ikena Oncology is currently generating about -0.27 per unit of risk. If you would invest 2,390 in Enliven Therapeutics on November 3, 2024 and sell it today you would lose (204.00) from holding Enliven Therapeutics or give up 8.54% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enliven Therapeutics vs. Ikena Oncology
Performance |
| Timeline |
| Enliven Therapeutics |
| Ikena Oncology |
Enliven Therapeutics and Ikena Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enliven Therapeutics and Ikena Oncology
The main advantage of trading using opposite Enliven Therapeutics and Ikena Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, Ikena Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ikena Oncology will offset losses from the drop in Ikena Oncology's long position.| Enliven Therapeutics vs. Pmv Pharmaceuticals | Enliven Therapeutics vs. Cullinan Oncology LLC | Enliven Therapeutics vs. Immuneering Corp | Enliven Therapeutics vs. Aerovate Therapeutics |
| Ikena Oncology vs. Edgewise Therapeutics | Ikena Oncology vs. Design Therapeutics | Ikena Oncology vs. Xilio Development | Ikena Oncology vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |